Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00365833 · ClinicalTrials.gov registry record
CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 8
- Enrollment target
NCT00365833 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 8 participants.
The verdict
NCT00365833 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
We believe that certain cells in the human body (Circulating Endothelial Cells and Endothelial Progenitor Cells) are related to risk of cardiovascular disease. It may be possible to measure levels of these cells in patients who have had a kidney transplant and predict their risk of developing cardiovascular disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00365833
The ClinicalTrials.gov registry entry for NCT00365833 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00365833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00365833 about?
NCT00365833 is a clinical study titled "CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients". We believe that certain cells in the human body (Circulating Endothelial Cells and Endothelial Progenitor Cells) are related to risk of cardiovascular disease. It may be possible to measure levels of these cells in patients who have had a kidney transplant and predict their risk of developing cardio...
What is the current status of trial NCT00365833?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2006-07. Estimated completion is 2007-02.
Who is sponsoring clinical trial NCT00365833?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.